Další formáty:
BibTeX
LaTeX
RIS
@proceedings{2296511,
author = {Vyklická, Kateřina and Bořilová Linhartová, Petra and Lipový, Břetislav},
booktitle = {RECETOX PhD Conference 2023},
keywords = {inhalation injury; biomarkers; microbiome; antibiotic resistance genes; miRNA; toxicology},
language = {eng},
title = {Molecular markers for risk stratification of early-and late-onset complications in patients with inhalation injury},
year = {2023}
}
TY - CONF
ID - 2296511
AU - Vyklická, Kateřina - Bořilová Linhartová, Petra - Lipový, Břetislav
PY - 2023
TI - Molecular markers for risk stratification of early-and late-onset complications in patients with inhalation injury
KW - inhalation injury
KW - biomarkers
KW - microbiome
KW - antibiotic resistance genes
KW - miRNA
KW - toxicology
N2 - Inhalation injury (INHI) is defined as an acute airway injury caused by inhalation of hot steam and/or products of combustion. Mortality in patients with INHI is often associated with the development of secondary complications such as extensive infections, pneumonia, direct mucosal damage, mucosal sloughing, and obstructions. Currently, it is acknowledged that the major problem lies in the lack of uniformity in diagnosis, grading, and treatment. The investigation of specific biomarkers for INHI has a great potential to address this issue. Such biomarkers could serve not only to unify diagnosis and treatment, but also to predict the development of secondary complications in patients with INHI. Due to the rarity of the injury, this complex project was designed as a prospective study with the aim of monitoring individual patient parameters during hospitalization. Samples of several matrices (buccal and oropharyngeal swabs, bronchoalveolar lavage - BAL, urine, and blood) for subsequent analyses are collected at 6 time points. In my thesis, I focus on the molecular biological aspects of INHI. Therefore, the main aims are: i) to determine the microbiome and antibiotic resistance genes in samples from upper and lower airways, blood, and/or urine of patients with INHI and with/without infectious complications during their hospitalization; and ii) to select miRNA correlating with INHI using RNAseq analysis in BAL and urine samples, and iii) to characterize toxic compound in BAL and urine.
ER -
VYKLICKÁ, Kateřina, Petra BOŘILOVÁ LINHARTOVÁ a Břetislav LIPOVÝ. Molecular markers for risk stratification of early-and late-onset complications in patients with inhalation injury. In \textit{RECETOX PhD Conference 2023}. 2023.
|
